Guardant Health
GH
#3091
Rank
$4.03 B
Marketcap
$32.65
Share price
5.39%
Change (1 day)
40.55%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2024 : -$60.1 Million USD

According to Guardant Health 's latest financial reports the company has -$60.1 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$0.15 B163.68%
2022-12-31$$60.18 M-90.67%
2021-12-31$$0.64 B-52.42%
2020-12-31$$1.35 B59.86%
2019-12-31$$0.84 B61.54%
2018-12-31$$0.52 B70.1%
2017-12-31$$0.30 B287.23%
2016-12-31$$79.69 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$0.83 B-1,491.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.13 B-5,316.97%๐Ÿ‡บ๐Ÿ‡ธ USA